S 3822119th CongressIn Committee
Break Up Big Medicine Act
Standard Summary
Balanced plain-English summary
This bill would prohibit common ownership between health insurers or pharmacy benefit managers and medical providers, and between drug or device wholesalers and providers, requiring divestment and creating federal, state, and private antitrust enforcement mechanisms.
Key Points
- 1Makes it unlawful for insurers or PBMs to own providers or management services organizations while also owning an insurer and a PBM.
- 2Bars prescription drug or medical device wholesalers from owning providers or management services organizations.
- 3Requires divestment within one year, with escrow penalties, trustee-led divestiture, and FTC and DOJ review.
- 4Authorizes the FTC, DOJ, HHS Inspector General, state attorneys general, and private plaintiffs to enforce the law, including treble damages and disgorgement.
Impact Areas
Health insurersPharmacy benefit managersHospitals and physician practicesDrug and device wholesalersPatients and consumersFTC and DOJState attorneys general
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026